JHMH - John Hancock Multifactor Healthcare ETF
| Assets | $51.90M |
| NAV | $46.34 |
| Expense Ratio | 0.40% |
| PE Ratio | 25.49 |
| Beta (5Y) | 0.82 |
| Dividend (ttm) | $1.09 |
| Dividend Yield | 2.36% |
| Ex-Dividend Date | Dec 24, 2020 |
| 1-Year Return | - |
| Trading Day | April 21 |
| Last Price | $46.92 |
| Previous Close | $46.30 |
| Change ($) | 0.62 |
| Change (%) | 1.33% |
| Day's Open | 46.01 |
| Day's Range | 46.81 - 46.92 |
| Day's Volume | 1,266 |
| 52-Week Range | 34.60 - 46.92 |
Fund Description
The investment seeks to provide investment results that closely correspond, before fees and expenses, to the performance of the John Hancock Dimensional Healthcare Index. The fund normally invests at least 80% of its net assets (plus any borrowings for investment purposes) in securities that compose the fund's index. The index is designed to comprise securities in the healthcare sector within the U.S. Universe whose market capitalizations are larger than that of the 1001st largest U.S. company at the time of reconstitution. The fund is non-diversified.
| Asset Class Equity | Sector Healthcare |
| Region North America | Inception Date Sep 29, 2015 |
| Exchange NYSEARCA | Ticker Symbol JHMH |
| Index Tracked John Hancock
Dimensional Healthcare Index | |
Top 10 Holdings
31.15% of assets| Name | Symbol | Weight |
|---|---|---|
| UnitedHealth | UNH | 6.05% |
| Johnson & Johnson | JNJ | 5.93% |
| Merck | MRK | 3.08% |
| Pfizer | PFE | 2.94% |
| Abbott Laboratories | ABT | 2.47% |
| Thermo Fisher Scientific | TMO | 2.31% |
| AbbVie | ABBV | 2.27% |
| Bristol-Myers Squibb | BMY | 2.09% |
| Anthem | ANTM | 2.05% |
| Medtronic | MDT | 1.96% |
Dividends
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 24, 2020 | $0.643 | Dec 30, 2020 |
| Jun 25, 2020 | $0.45 | Jun 30, 2020 |
| Dec 24, 2019 | $0.239 | Dec 30, 2019 |
| Jun 25, 2019 | $0.671 | Jun 28, 2019 |
| Dec 24, 2018 | $0.144 | Dec 28, 2018 |
| Jun 26, 2018 | $0.1036 | Jun 29, 2018 |
While 2020 may feel like a “this time it's different” year, the reality is the core underpinnings of what makes for a winning portfolio haven't changed: controlling expenses, managing your taxes, and mo...
As more take a harder look at their portfolio composition, many investors are turning to smart beta exchange traded funds to enhance their portfolios and meet the challenges ahead. “They’re kind of real...